• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCB
Click for more information
0.39% $20.37

RUSSELL AUSTRALIAN SELECT CORPORATE BOND ETF

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RCB
Ann: Dividend/Distribution - RCB 		22/03/19 0 55
22/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  55 
RCB
Ann: Interim Financial Report 		15/03/19 0 59
15/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  59 
RCB
Ann: Monthly Units On Issue Announcement 		04/03/19 0 68
04/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  68 
RCB
Ann: Monthly Units On Issue Announcement 		04/02/19 0 69
04/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  69 
RCB
Ann: Final Distribution Announcement - December 2018 		07/01/19 0 77
07/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  77 
RCB
Ann: Update - Dividend/Distribution - RCB 		07/01/19 0 76
07/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  76 
RCB
Ann: Monthly Units On Issue Announcement 		03/01/19 0 94
03/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  94 
RCB
Ann: Dividend/Distribution - RCB 		24/12/18 0 127
24/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  127 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.